Shadow On Novartis’ Ceritinib In India After Patent Revoked – Scrip

Shadow On Novartis’ Ceritinib In India After Patent Revoked  Scrip

A patent on Novartis’ceritinib has been rescinded in India, giving challenger Natco the upper hand, though the Swiss multinational has filed an appeal and …